Immunologically mediated signaling in basophils and mast cells: Finding therapeutic targets for allergic diseases in the human FcεRI signaling pathway

Immunopharmacology

Volumn 48, Issue 3, 2000, Pages 269-281

  Oliver, Janet M ^a   Kepley, Christopher L ^a   Ortega, Enrique ^b   Wilson, Bridget S ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b INSTITUTO DE INVESTIGACIONES BIOMÉDICAS   (Mexico)

Author keywords

Allergy; Anti IgE; Antigen presenting cells; Asthma; Basophil; Cytokine production; Degranulation; Fc RII; Fc RI; IgE; IgG; Immunotherapy; Inflammation; ITAM; ITIM; Lyn; Mast cell; Piceatannol; Secretion; Syk; Tyrosine kinase

Indexed keywords

CYTOKINE; ER 27319; FC RECEPTOR; IMMUNOGLOBULIN E RECEPTOR; IMMUNOGLOBULIN G; PICEATANNOL; PROTEIN INHIBITOR; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ALLERGIC DISEASE; ALLERGIC RHINITIS; ANAPHYLAXIS; ANTIGEN PRESENTATION; ASTHMA; ATOPIC DERMATITIS; BASOPHIL; CELL ACTIVATION; CONFERENCE PAPER; CYTOKINE PRODUCTION; DEGRANULATION; DENDRITIC CELL; ENZYME INACTIVATION; HUMAN; IMMUNE RESPONSE; IMMUNOTHERAPY; INFLAMMATION; MACROPHAGE; MAST CELL; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; URTICARIA;

ANIMALS; BASOPHILS; ENZYME PRECURSORS; HUMANS; HYPERSENSITIVITY; IMMUNOTHERAPY; INFLAMMATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAST CELLS; PROTEIN ISOFORMS; PROTEIN-TYROSINE KINASES; RECEPTORS, IGE; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES;

EID: 0034713675     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(00)00224-1     Document Type: Conference Paper

References (34)

1. Anselmino L.M., Perussia B., Thomas L.L. Human basophils selectively express the FcγRII (CDw32) subtype of IgG receptor. J. Allergy Clin. Immunol. 84:1989;907-914.
2. Bieber T. FcεRI on antigen-presenting cells. Curr. Opin. Immunol. 8:1996;773-777.
3. Bochner B.S., Sterbinsky S.A., Saini S.A., Colombo M., MacGlashan D.W. Studies of cell adhesion and flow cytometric analyses of degranulation and surface phenotype and viability using human eosinophils, basophils and mast cells. Methods: A Companion to Methods in Enzymology. 13:1997;61-68.
4. Cambier J.C. Inhibitory receptors abound? Proc. Natl. Acad. Sci. 94:1997;5993-5995.
5. Daeron M. Fc receptor biology. Annu. Rev. Immunol. 5:1997;203-234.
6. Guthman M.D., Tal M., Pecht I. A secretion inhibitory signal transduction molecule on mast cells is another C-type lectin. Proc. Natl. Acad. Sci. 92:1995;9397-9401.
7. Hamawy M.M. The high affinity IgE receptor (FcεRI): structure and function. 1997;R.G. Landes, Austin, TX.
8. Heusser C., Jardieu P. Therapeutic potential of anti-IgE antibodies. Curr. Opin. Immunol. 9:1997;805-814.
9. Hutchcroft J.E., Geahlen R.L., Deanin G.G., Oliver J.M. FcεRI-mediated tyrosine phosphorylation and activation of the 72 kDa protein tyrosine kinase, PTK72, in RBL-2H3 rat tumor mast cells. Proc. Natl. Acad. Sci. 89:1992;9107-9111.
10. Jiang G., Hunter T. Receptor signaling: When dimerization is not enough. Curr. Biol. 9:1998;R568-R571.
11. Joazeiro C.A., Wing S.S., Huang H.-K., Leverson J.D., Hunter T., Liu Y.-C. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase. Science. 286:1991;309-312.
12. Kepley C.L., Wilson B.S., Oliver J.M. Roles for the protein kinases Lyn, Syk and Zap70 in FcεRI-mediated human basophil degranulation. J. Allergy Clin. Immunol. 102:1998;304.
13. Kepley C.L., Pfeiffer J.R., Schwartz L.B., Wilson B.S., Oliver J.M. The identification and characterization of umbilical cord blood-derived human basophils. J. Leukocyte Biol. 64:1998;474-483.
14. Kepley C.L., Youssef L., Andrews R.P., Wilson B.S., Oliver J.M. Syk deficiency in non-releaser basophils. J. Allergy Clin. Immunol. 104:1999;279-284.
15. Kepley C.L., Lujan D., Ortega E., Morel P.A., Wilson B.S., Oliver J.M. Negative regulation of FcεRI signaling by co-crosslinking to FcγRII in human blood basophils. 1999;. submitted for publication.
16. Kersh G.K., Kersh E.N., Fremont D.H., Allen P.M. High- and low-potency ligands with similar affinities for the TCR: the importance of kinetics in TCR signaling. Immunity. 9:1998;817-826.
17. Kinet J.-P. The high-affinity IgE receptor (FcεRI): from physiology to pathology. Annu. Rev. Immunol. 17:1999;931-972.
18. Lupher M.L., Rao N., Eck M.J., Band H. The Cbl protooncogene: a negative regulator of immune receptor signal transduction. Immunol. Today. 20:1999;375-382.
19. Metzger H. It's spring, and thoughts turn to allergies. Cell. 97:1999;287-290.
20. Moriya K., Rivera J., Odom S., Sakuma Y., Yoshiuchi T., Miyamoto M., Yamada K. ER-27319, an acridone-related compound, inhibits release of antigen-induced allergic mediators from mast cells by selective inhibition of the FcεRI-mediated activation of Syk. Proc. Natl. Acad. Sci. 94:1997;12539-12544.
21. Oliver J.M., Burg D.L., Wilson B.S., McLaughlin J.L., Geahlen R.L. Inhibition of mast cell FcεRI-mediated signalling and effector function by the Syk-selective inhibitor, piceatannol. J. Biol. Chem. 269:1994;2703-2969.
22. Ortega E., Schweitzer-Stenner R., Pecht I. Possible orientational constraints determine secretory signals induced by aggregation of IgE receptors on mast cells. EMBO J. 7:1988;4101-4109.
23. Ortega E., Lara M., Lee I., Santana C., Martinez A.M., Pfeiffer J.R., Lee R.J., Wilson B.S., Oliver J.M. Lyn dissociation from phosphorylated FcεRI subunits: a new regulatory step in the FcεRI signaling cascade revealed by studies of FcεRI dimer signaling activity. J. Immunol. 162:1999;176.
24. Raposo G., Tenza D., Mecheri S., Peronet R., Bonnerot C., Desaymard C. Accumulation of major histocompatability complex class II molecules in mast cell secretory granules and their release upon degranulation. Mol. Biol. Cell. 8:1997;2631-2645.
25. Razin E., Rivera J. Signal transduction in mast cells and basophils. 1999;Springer, New York.
26. Rivera V.M., Brugge J.S. Clustering of Syk is sufficient to induce tyrosine phosphroylation and release of allergic mediators from rat basophilic leukemia cells. Mol. Cell. Biol. 15:1995;1582-1590.
27. Saini S.S., MacGlashan D.W., Sterbinsky S.A., Togias A., Adelman D.C., Lichtenstein L.M., Bochner B.S. Down-regulation of human basophil IgE and FcεRI α surface densities and mediator release by anti-IgE-infusions is reversible in vitro and in vivo. J. Immunol. 162:1999;5624-5630.
28. Saito H., Ebisawa M., Sakaguchi N., Onda T., Ikura Y., Yanagida M., Uzumaki H., Nakahata T. Characterization of cord-blood-derived human mast cells cultured in the presence of steel factor and interleukin-6. Int. Arch. Allergy Immunol. 107:1995;63-65.
29. Sanan D.A., Anderson R.G.W. Simultaneous visualization of LDL receptor distribution and clathrin lattices on membranes torn from the upper surface of cultured cells. J. Histochem. Cytochem. 39:1991;1017-1024.
30. Stingl G., Maurer D. IgE-mediated allergen presentation via FcεRI on antigen-presenting cells. Int. Arch. Allergy Immunol. 113:1997;24-29.
31. Tkaczyk C., Villa I., Peronet R., Mecheri S. FcεRI-mediated antigen endocytosis turns interferon-gamma-treated mouse mast cells from inefficient into potent antigen-presenting cells. Immunology. 97:1999;333-340.
32. Watson S.P., Gibbins J. Collagen receptor signaling in platelets: extending the role of the ITAM. Immunol. Today. 19:1998;260-264.
33. Wofsy C., Torigoe C., Kent U.M., Metzger H., Goldstein B. Exploiting the difference between intrinsic and extrinsic kinases: Implications for regulation of signaling by immunoreceptors. J. Immunol. 159:1997;5984-5992.
34. Wofsy C., Vonakis B.M., Metzger H., Goldstein B. One Lyn molecule is sufficient to initiate phosphorylation of aggregated high-affinity IgE receptors. Proc. Natl. Acad. Sci. 96:1999;8615-8620.